REmote Symptom COllection to improVE postopeRative Care
Purpose
There are vulnerabilities in post-discharge care transition for patients after undergoing resection of malignant gastrointestinal tumors. This study aims to investigate the possibility of utilizing Voice-Assisted Remote Symptom Monitoring System (VARSMS) to alleviate some of these challenges.
Condition
- Gastrointestinal Cancer
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- At least 18 years old. Ages of subjects >89 will simply be reported as >90. 2. Scheduled for a GI surgery for management of a tumor in a participating hospital. 3. Fluent in oral and written English. 4. Has consistent and continued full access to an operational Wi-Fi for the duration of the study.
Exclusion Criteria
- Unable to provide informed consent. 2. Not willing to commit to regular participation in the study to include daily use (40 days) of the study application. 3. Life expectancy of less than 60 days. 4. In the opinion of the investigator, participation in this study is contraindicated.
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Intervention Model Description
- The Voice-Assisted Remote Symptom Monitoring System (VARSMS) will be installed on Amazon Echo Dot
- Primary Purpose
- Supportive Care
- Masking
- None (Open Label)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
No Intervention Control |
Besides the consent process, subjects in this arm will have no other research-specific activities until after 40 days after the surgery for an exit interview. |
|
Experimental Voice-Assisted Remote Symptom Monitoring System (VARSMS) group |
Subjects in this group will be issued the device, to be activated 1 day after discharge. The device will administer a set of questions daily. |
|
Recruiting Locations
MedStar Health
Baltimore, Maryland 21218
Baltimore, Maryland 21218
More Details
- Status
- Recruiting
- Sponsor
- Medstar Health Research Institute